SLPSimulations Plus, Inc.

NAS · US · Healthcare · Health Information Services · simulations-plus.com

18.40USD+0.16%Mkt Cap: 372.14M $P/E: 46.003d ago

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc Class A

$40.27BUSDP/E 44.0

TEM

Tempus AI Inc. Class A Common Stock

$13.12BUSD

BTSG

BrightSpring Health Services Inc. Common Stock

Hinge Health Inc. Class A Common Stock

$7.14BUSDP/E 10.8

WAY

Waystar Holding Corp. Common Stock

$4.80BUSDP/E 35.7

DOCS

Doximity Inc. Class A Common Stock

$4.51BUSDP/E 30.2

HTFL

Heartflow Inc. Common Stock

$4.33BUSD

PRVA

Privia Health Group, Inc.

Omada Health Inc. Common Stock

GoodRx Holdings, Inc.

Talkspace Inc. Common Stock

SOPHiA GENETICS SA Ordinary Shares

$736.36MUSD

Key Statistics

Company

Market Cap372.14M $

Enterprise Value322.23M $

Revenue (TTM)82.06M $

Gross Profit46.22M $

Net Income (TTM)-64.72M $

Revenue/Share4.070 USD

Last Price18.40 USD

Fiscal Year EndAug 2025

MR QuarterMay 2026

Employees212

CountryUS

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)46.00

P/E (Forward)20.83

PEG9.88

EV/EBITDA21.46

EV/Revenue3.93

P/S4.53

P/B2.67

EPS (TTM)0.40

EPS (Forward)0.88

52W Range

11.0974% of range21.01

52W High21.01 USD

52W Low11.09 USD

Profitability

Gross Margin58.38%

Oper. Margin22.84%

EBITDA Margin18.30%

Profit Margin-81.74%

ROE-51.86%

ROA-49.05%

Growth

Revenue Growth7.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF18.13M $

CapEx (TTM)3.72M $

FCF Margin22.43%

FCF Yield4.95%

Net Debt-49.50M $

Net Debt/EBITDA-3.30

Balance Sheet

Debt/Equity0.00

Current Ratio5.54

Quick Ratio5.31

Book Value/Sh6.877 USD

Cash/Share2.472 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield0.52%

Payout Ratio0.00%

Ex-Div DateJul 29, 2024

Pay DateAug 5, 2024

Splits

Last Split2:1

Split DateOct 2, 2007

Analyst Consensus

Rating—

Target (Mean)17.25 USD

Upside (mean)-6.2%

Target Range16.00 USD – 18.50 USD

$16.00-6.2% to mean$18.50

# Analysts2

Ownership

Shares Out.20.22M

Float16.81M

Insiders16.91%

Institutions78.81%

Short Interest

Short Ratio5.7d

Short % Float19.83%

Short % Out.14.06%

Shares Short2.84M

Short (prev mo.)1.23M

Technical

SMA 5018.13 (+1.5%)

SMA 20016.28 (+13.0%)

Beta1.33

S&P 52W Chg18.16%

Avg Vol (30d)361.57K

Avg Vol (10d)194.44K

Technical Indicators

RSI (14)64.6

MACD0.1091

MACD Signal0.1405

MACD Hist.-0.0314

BB Upper18.40 USD

BB Middle18.33 USD

BB Lower18.26 USD

BB Width0.73%

ATR (14)0.1000 USD

Vol Ratio (20d)0.41x